Court denies $5B class action over alleged drug price fixing
The Federal Court has denied the certification of a proposed class action seeking $5 billion in damages against pharmaceutical companies for allegedly conspiring to fix drug prices in Canada and the...To view the full article, register now.
Already a subscriber? Click here to view full article